Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court
A Merck Sharp Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan Pharmaceuticals Inc.
Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court
A Merck Sharp Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan Pharmaceuticals Inc.